Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
7th grade Avg
|
Filing tables
Filing exhibits
- 40-F Annual report (Canada)
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
- 99.9 EX-99.9
- 99.10 EX-99.10
- 99.11 EX-99.11
- 99.12 EX-99.12
- 99.13 EX-99.13
- 99.14 EX-99.14
- 99.15 EX-99.15
- 99.16 EX-99.16
- 99.17 EX-99.17
- 99.18 EX-99.18
- 99.19 EX-99.19
- 99.20 EX-99.20
- 99.21 EX-99.21
- 99.22 EX-99.22
- 99.23 EX-99.23
- 99.24 EX-99.24
- 99.25 EX-99.25
- 99.26 EX-99.26
- 99.27 EX-99.27
- 99.28 EX-99.28
- 99.29 EX-99.29
- 99.30 EX-99.30
- 99.31 EX-99.31
- 99.32 EX-99.32
- 99.33 EX-99.33
- 99.34 EX-99.34
- 99.35 EX-99.35
- 99.36 EX-99.36
- 99.37 EX-99.37
- 99.38 EX-99.38
- 99.39 EX-99.39
- 99.40 EX-99.40
- 99.41 EX-99.41
- 99.42 EX-99.42
- 99.43 EX-99.43
- 99.44 EX-99.44
- 99.45 WX-99.45
- 99 EX-99-46
- 99.47 EX-99.47
- 99.48 EX-99.48
- 99.49 EX-99.49
- 99.50 EX-99.50
- 99.51 EX-99.51
- 99.52 EX-99.52
- 99.53 EX-99.53
- 99.54 EX-99.54
- 99.55 EX-99.55
- 99.56 EX-99.56
- 99.57 EX-99.57
- 99.58 EX-99.58
- 99.59 EX-99.59
- 99.60 EX-99.60
- 99.61 EX-99.61
- 99.62 EX-99.62
- 99.63 EX-99.63
- 99.64 EX-99.64
- 99.65 EX-99.65
- 99.66 EX-99.66
- 99.67 EX-99.67
- 99.68 EX-99.68
- 99.69 EX-99.69
- 99.70 EX-99.70
- 99.71 EX-99.71
- 99.72 EX-99.72
- 99.73 EX-99.73
- 99.74 EX-99.74
- 99.75 EX-99.75
- 99.76 EX-99.76
- 99.77 EX-99.77
- 99.78 EX-99.78
- 99.79 EX-99.79
- 99.80 EX-99.80
- 99.81 EX-99.81
- 99.82 EX-99.82
- 99.83 EX-99.83
- 99.84 EX-99.84
- 99.85 EX-99.85
- 99.86 EX-99.86
- 99.87 EX-99.87
- 99.88 EX-99.88
- 99.89 EX-99.89
- 99.90 EX-99.90
- 99.91 EX-99.91
- 99.92 EX-99.92
THTX similar filings
Filing view
External links
Exhibit 99.32
MATERIAL CHANGE REPORT
Regulation 51-102 Respecting Continuous Disclosure Obligations
Form 51-102F3
Regulation 51-102 Respecting Continuous Disclosure Obligations
Form 51-102F3
1. | NAME AND ADDRESS OF COMPANY: | |
THERATECHNOLOGIES INC. 2310 Alfred-Nobel Boulevard Montreal, Québec Canada H4S 2B4 | ||
2. | DATE OF MATERIAL CHANGE: | |
June 2, 2011 | ||
3. | NEWS RELEASE: | |
A news release describing this material change was issued on June 2, 2011 on “Marketwire”. A copy of the news release is available on the SEDAR website at www.sedar.com. | ||
4. | SUMMARY OF MATERIAL CHANGE: | |
On June 2, 2011, Theratechnologies Inc. (the “Corporation”) announced that it had re-evaluated its research and development business model (the “R&D Model”). The review of the R&D Model resulted in the collective dismissal of 24 employees and the Corporation estimates a reduction in payroll expenses of approximately $300,000 for the remainder of fiscal 2011 and approximately $2.5 million for fiscal 2012. | ||
5. | FULL DESCRIPTION OF MATERIAL CHANGE: | |
On June 2, 2011, the Corporation announced that it had re-evaluated its R&D Model. The Corporation intends to call upon partners in the public and private arena to help it bring its research and development project forward. The review of the R&D Model resulted in the collective dismissal of 24 employees and the Corporation estimates a reduction in payroll expenses of approximately $300,000 for the remainder of fiscal 2011 and approximately $2.5 million for fiscal 2012. | ||
6. | RELIANCE ON SUBSECTION 7.1(2) OR (3) OF NATIONAL INSTRUMENT 51-102: | |
Not applicable. | ||
7. | OMITTED INFORMATION: | |
Not applicable. |
- 2 -
8. | EXECUTIVE OFFICER: | |
For further information, contact Jocelyn Lafond, Vice President, Legal Affairs, and Corporate Secretary of the Company at (514) 336-4804, ext. 288. | ||
9. | DATE OF REPORT: | |
June 3, 2011 |